Skip to main content
. 2000 Feb;44(2):428–432. doi: 10.1128/aac.44.2.428-432.2000

TABLE 1.

MICS of β-lactams

Antibiotic MIC (μg/ml)a
A. baumannii RYC 52763/97 E. coli TG1 E. coli TG1 (pGER1) E. coli TG1 (pGER2)
Ampicillin >1,024 4 128 >1,024
Ampicillin plus clavulanic acidb >1,024 4 64 128
Ampicillin plus sulbactamb >1,024 2 16 >1,024
Ampicillin plus tazobactamb >1,024 2 32 64
Ticarcillin >1,024 4 32 >1,024
Cefazolin >256 8 >256 >256
Cefuroxime >256 4 >256 >256
Cefoxitin >256 4 4 4
Cefotaxime >256 ≤0.125 4 8
Cefotaxime plus clavulanic acid >256 ≤0.125 2 4
Cefotaxime plus sulbactam >256 ≤0.125 0.25 2
Cefotaxime plus tazobactam >256 ≤0.125 0.5 1
Ceftazidime >256 ≤0.125 16 32
Ceftazidime plus clavulanic acid >256 ≤0.125 8 16
Ceftazidime plus sulbactam >256 ≤0.125 1 8
Ceftazidime plus tazobactam >256 ≤0.125 2 4
Cefepime 256 ≤0.125 0.25 0.5
Aztreonam >256 ≤0.125 1 4
Imipenem 128 0.25 0.25 0.25
Meropenem 256 0.03 0.03 0.03
a

Enzymes are as follows: for A. baumannii RYC 52763/97, AmpC plus a β-lactamase with a pI of 9.0 plus TEM-1; for E. coli TG1(pGER1), AmpC; and for E. coli TG1(pGER2), AmpC plus TEM-1. Clone E. coli TG1(pGER2) harbored the ampC gene in the pUC18 multicopy plasmid (containing the blaTEM-1 resistance marker). 

b

Concentration of β-lactamase inhibitor was 4 μg/ml.